CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and ¹¹C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer’s disease

References

• Mesulam MM. Primary progressive aphasia. Ann Neurol 2001;49:425–32
   PubMed Web of Science ®Google Scholar
• Ogar JM, Dronkers NF, Brambati SM, Miller BL, Gorno-Tempini ML. Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord 2007;21:S23–30
   PubMed Web of Science ®Google Scholar
• Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol 2012;11:545–55
   PubMed Web of Science ®Google Scholar
• Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115:1783–806
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–54
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, La Phengrasamy BA, Rosen HJ, Johnson JK, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335–46
   PubMed Web of Science ®Google Scholar
• Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O’Neil JP, et al. Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008;64:388–401
   PubMed Web of Science ®Google Scholar
• Kas A, Uspenskaya O, Lamari F, de Souza LC, Habert MO, Dubois B, Teichmann M, et al. Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia. J Neurol Neurosurg Psychiatry 2012;83:695–8
   PubMedGoogle Scholar
• Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A, Perani D, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008;71:1227–34
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006–14
   PubMed Web of Science ®Google Scholar
• Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, et al. Amyloid beta(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 2004;62:1580–4
   PubMed Web of Science ®Google Scholar
• Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306–19
   PubMed Web of Science ®Google Scholar
• Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimer’s disease. Lancet Neurol 2011;10:667–70
   PubMed Web of Science ®Google Scholar
• Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Otto M, Kornhuber J, et al. Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias. Dement Geriatr Cogn Disord 2011;31:37–44
   PubMedGoogle Scholar
• Gil-Navarro S, Lladó A, Rami L, Castellví M, Bosch B, Bargalló N, Lomeña F, et al. Neuroimaging and biochemical markers in the three variants of primary progressive aphasia. Dement Geriatr Cogn Disord 2013;35:106–17
   PubMed Web of Science ®Google Scholar
• Josephs KA, Duffy JR, Fossett TR, Strand EA, Claassen DO, Whitwell JL, Peller PJ. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol 2010;67:596–605
   PubMed Web of Science ®Google Scholar
• Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, Piguet O, Burrell JR, et al. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging. Brain 2011;134:3030–43
   PubMed Web of Science ®Google Scholar
• Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011;76:1804–10
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98
   PubMed Web of Science ®Google Scholar
• Holsinger T, Deveau J, Boustani M, Williams JW Jr. Does this patient have dementia? JAMA 2077;297:2391–404
   Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of health and human services task force on alzheimer's disease. Neurology 1984;34:939–44
   PubMed Web of Science ®Google Scholar
• Mimura M, Kato M, Kato M, Sano Y, Kojima T, Naeser M, Kashima H. Prospective and retrospective studies of recovery in aphasia. Changes in cerebral blood flow and language functions. Brain 1998;121:2083–94
   PubMed Web of Science ®Google Scholar
• Funayama M, Nakagawa Y, Yamaya Y, Yoshino F, Mimura M, Kato M. Progression of logopenic variant primary progressive aphasia to apraxia and semantic memory deficits. BMC Neurol 2013;13:158
   Google Scholar
• Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, Meltzer CC, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 2005;46:1959–72
   PubMed Web of Science ®Google Scholar
• Ikeda M, Hirayanagi K, Arai M, Kakuda S, Makioka K, Furuta N, Takai E, et al. Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42. Amyloid 2012;19:186–90
   PubMed Web of Science ®Google Scholar
• Ikeda M, Yonemura K, Kakuda S, Tashiro Y, Fujita Y, Takai E, Hashimoto Y, et al. Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations. Amyloid 2013;20:107–12
   PubMed Web of Science ®Google Scholar
• Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjögren M, Andreasen N, et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 2000;285:49–52
   PubMed Web of Science ®Google Scholar
• Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158–9
   PubMed Web of Science ®Google Scholar
• Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993;163:166–8
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, et al. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994;36:656–9
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Rossor MN, Warren JD. Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging 2012;33:744–52
   PubMed Web of Science ®Google Scholar
• Irwin DJ, Trojanowski JQ, Grossman M. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease. Front Aging Neurosci 2013;5:6
   PubMedGoogle Scholar
• Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol 2010;6:88–97
   PubMed Web of Science ®Google Scholar
• Migliaccio R, Agosta F, Rascovsky K, Karydas A, Bonasera S, Rabinovici GD, Miller BL, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 2009;73:1571–8
   PubMed Web of Science ®Google Scholar
• Magnin E, Sylvestre G, Lenoir F, Dariel E, Bonnet L, Chopard G, Tio G, et al. Logopenic syndrome in posterior cortical atrophy. J Neurol 2013;260:528–33
   PubMed Web of Science ®Google Scholar
• Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 2013;79:1094–108
   PubMed Web of Science ®Google Scholar